Literature DB >> 16766767

Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase.

R Moreno-Otero, M Trapero-Marugan, J Mendoza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16766767      PMCID： PMC1856318     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

Review 1.  Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.

Authors:  Alfredo Alberti
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

2.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

3.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Authors:  Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

4.  Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.

Authors:  Stefan Zeuzem; Moisés Diago; Edward Gane; K Rajender Reddy; Paul Pockros; Daniele Prati; Mitchell Shiffman; Patrizia Farci; Norman Gitlin; Christopher B O'Brien; François Lamour; Pilar Lardelli
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

5.  Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.

Authors:  L Benvegnù; M Gios; S Boccato; A Alberti
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 7.  Evaluation of liver fibrosis: a concise review.

Authors:  Nezam H Afdhal; David Nunes
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

8.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998
  8 in total
  6 in total

1.  Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Masato Yoneda; M Yoneda; Masashi Yoneda; Koji Fujita; K Fujita; Masahiko Inamori; M Inamori; Masaya Tamano; M Tamano; Hideyuki Hiriishi; H Hiraishi; Atsushi Nakajima; A Nakajima
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

2.  Performance of real-time elastography for the staging of hepatic fibrosis: a meta-analysis.

Authors:  Huisuo Hong; Jia Li; Yin Jin; Qiao Li; Weimin Li; Jiansheng Wu; Zhiming Huang
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

3.  Diagnostic Accuracy of Real-Time Shear Wave Elastography for Staging of Liver Fibrosis: A Meta-Analysis.

Authors:  Changtian Li; Changsheng Zhang; Junlai Li; Huiping Huo; Danfei Song
Journal:  Med Sci Monit       Date:  2016-04-22

Review 4.  Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment.

Authors:  Leen J M Heyens; Dana Busschots; Ger H Koek; Geert Robaeys; Sven Francque
Journal:  Front Med (Lausanne)       Date:  2021-04-14

5.  Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease.

Authors:  Guido Engelmann; Georg Friedrich Hoffmann; Juergen Grulich-Henn; Ulrike Teufel
Journal:  Hepat Mon       Date:  2014-04-07       Impact factor: 0.660

6.  Galectin-1 gene silencing inhibits the activation and proliferation but induces the apoptosis of hepatic stellate cells from mice with liver fibrosis.

Authors:  Zhi-Jun Jiang; Qing-Hua Shen; Hai-Yong Chen; Zhe Yang; Ming-Qi Shuai; Shu-Sen Zheng
Journal:  Int J Mol Med       Date:  2018-10-23       Impact factor: 4.101
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.